Unknown

Dataset Information

0

CYP2J2/EET reduces vulnerability to atrial fibrillation in chronic pressure overload mice.


ABSTRACT: Growing evidence has well established the protective effects of CYP2J2/EET on the cardiovascular system. The aim of the present study was to determine whether CYP2J2/EET has a preventive effect on atrial fibrillation (AF) and to investigate the underlying mechanisms. Wild-type mice were injected with or without AAV9-CYP2J2 before abdominal aortic constriction (AAC) operation. After 8 weeks, compared with wild-type mice, AAC mice display higher AF inducibility and longer AF durations, which were remarkably attenuated with AAV9-CYP2J2. Also, AAV9-CYP2J2 reduced atrial fibrosis area and the deposit of collagen-I/III in AAC mice, accompanied by the blockade of TGF-β/Smad-2/3 signalling pathways, as well as the recovery in Smad-7 expression. In vitro, isolated atrial fibroblasts were administrated with TGF-β1, EET, EEZE, GW9662, SiRNA Smad-7 and pre-MiR-21, and EET was demonstrated to restrain the differentiation of atrial fibroblasts largely dependent on Smad-7, due to the inhibition of EET on MiR-21. In addition, increased inflammatory cytokines, as well as activated NF-κB pathways induced by AAC surgery, were also significantly blunted by AAV9-CYP2J2 treatment. These effects of CYP2J2/EET were partially blocked by GW9662, the antagonist of PPAR-γ. In conclusion, this study revealed that CYP2J2/EET ameliorates atrial fibrosis through modulating atrial fibroblasts activation by disinhibition of MiR-21 on Smad-7, and attenuates atrial inflammatory response by repressing NF-κB pathways, reducing the vulnerability to AF, and CYP2J2/EET exerts its role at least partially through PPAR-γ activation. Our findings might provide a novel upstream therapeutic strategy for AF.

SUBMITTER: Li X 

PROVIDER: S-EPMC6933320 | biostudies-literature | 2020 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

CYP2J2/EET reduces vulnerability to atrial fibrillation in chronic pressure overload mice.

Li Xuguang X   Zhu Feng F   Meng Weidong W   Zhang Feng F   Hong Jiang J   Zhang Guobing G   Wang Fang F  

Journal of cellular and molecular medicine 20191120 1


Growing evidence has well established the protective effects of CYP2J2/EET on the cardiovascular system. The aim of the present study was to determine whether CYP2J2/EET has a preventive effect on atrial fibrillation (AF) and to investigate the underlying mechanisms. Wild-type mice were injected with or without AAV9-CYP2J2 before abdominal aortic constriction (AAC) operation. After 8 weeks, compared with wild-type mice, AAC mice display higher AF inducibility and longer AF durations, which were  ...[more]

Similar Datasets

| S-EPMC10823351 | biostudies-literature
| S-EPMC7348162 | biostudies-literature
| S-EPMC6073148 | biostudies-literature
| S-EPMC3772848 | biostudies-literature
| S-EPMC11335301 | biostudies-literature
| S-EPMC5726581 | biostudies-literature
| S-EPMC6502694 | biostudies-literature
2021-12-30 | GSE192643 | GEO
| S-EPMC3087982 | biostudies-other
| S-EPMC10692773 | biostudies-literature